subject area of
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer Academic Article
- A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer Academic Article
- Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis Academic Article
- Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer Academic Article
- Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review Academic Article
- Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer Academic Article
- Chemoprevention: Drug pricing and mortality Academic Article
- Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy Academic Article
- Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial Academic Article
- Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17 Academic Article
- Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference Academic Article
- Endocrine symptoms to predict risk of recurrence? Academic Article
- Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination Academic Article
- Estradiol increases extracellular levels of vascular endothelial growth factorin vivo in murine mammary cancer Academic Article
- Extended Adjuvant Endocrine Therapy in Breast Cancer: Current Status and Future Directions Academic Article
- Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Academic Article
- Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17 Academic Article
- Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: A mechanistic model supporting prevention strategies Academic Article
- Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen Academic Article
- Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Academic Article
- Ovarian ablation as adjuvant therapy for early-stage breast cancer. Academic Article
- Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer. Academic Article
- Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells Academic Article
- Preparation and Evaluation of Carborane Analogues of Tamoxifen Academic Article
- Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement. Academic Article
- Systematic Review on Hormone Receptor Testing in Breast Cancer Academic Article
- Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin Academic Article
- The Use of Endocrine Therapy Academic Article
- Trends in endocrine therapy and chemotherapy for early breast cancer: a focus on the premenopausal patient Academic Article